171 related articles for article (PubMed ID: 25463045)
1. Stanniocalcin-2 (STC2): A potential lung cancer biomarker promotes lung cancer metastasis and progression.
Na SS; Aldonza MB; Sung HJ; Kim YI; Son YS; Cho S; Cho JY
Biochim Biophys Acta; 2015 Jun; 1854(6):668-76. PubMed ID: 25463045
[TBL] [Abstract][Full Text] [Related]
2. Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells.
Law AY; Wong CK
Exp Cell Res; 2010 Dec; 316(20):3425-34. PubMed ID: 20619259
[TBL] [Abstract][Full Text] [Related]
3. Stanniocalicin 2 suppresses breast cancer cell migration and invasion via the PKC/claudin-1-mediated signaling.
Hou J; Wang Z; Xu H; Yang L; Yu X; Yang Z; Deng Y; Meng J; Feng Y; Guo X; Yang G
PLoS One; 2015; 10(4):e0122179. PubMed ID: 25830567
[TBL] [Abstract][Full Text] [Related]
4. STC2 Is a Potential Prognostic Biomarker for Pancreatic Cancer and Promotes Migration and Invasion by Inducing Epithelial-Mesenchymal Transition.
Lin C; Sun L; Huang S; Weng X; Wu Z
Biomed Res Int; 2019; 2019():8042489. PubMed ID: 32258098
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of stanniocalcin 2 expression as a predictor of tumor progression in gastric cancer.
Arigami T; Uenosono Y; Ishigami S; Yanagita S; Hagihara T; Haraguchi N; Matsushita D; Hirahara T; Okumura H; Uchikado Y; Nakajo A; Hokita S; Natsugoe S
Oncol Rep; 2013 Dec; 30(6):2838-44. PubMed ID: 24100594
[TBL] [Abstract][Full Text] [Related]
6. STC2 promotes head and neck squamous cell carcinoma metastasis through modulating the PI3K/AKT/Snail signaling.
Yang S; Ji Q; Chang B; Wang Y; Zhu Y; Li D; Huang C; Wang Y; Sun G; Zhang L; Guan Q; Xiang J; Wei W; Lu Z; Liao T; Meng J; Wang Z; Ma B; Zhou L; Wang Y; Yang G
Oncotarget; 2017 Jan; 8(4):5976-5991. PubMed ID: 27863406
[TBL] [Abstract][Full Text] [Related]
7. Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target.
Qie S; Sang N
J Exp Clin Cancer Res; 2022 May; 41(1):161. PubMed ID: 35501821
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance of stanniocalcin 2 gene expression in colorectal cancer.
Ieta K; Tanaka F; Yokobori T; Kita Y; Haraguchi N; Mimori K; Kato H; Asao T; Inoue H; Kuwano H; Mori M
Int J Cancer; 2009 Aug; 125(4):926-31. PubMed ID: 19415750
[TBL] [Abstract][Full Text] [Related]
9. STC2 is upregulated in hepatocellular carcinoma and promotes cell proliferation and migration in vitro.
Wang H; Wu K; Sun Y; Li Y; Wu M; Qiao Q; Wei Y; Han ZG; Cai B
BMB Rep; 2012 Nov; 45(11):629-34. PubMed ID: 23187001
[TBL] [Abstract][Full Text] [Related]
10. Stanniocalcin 2 contributes to aggressiveness and is a prognostic marker for oral squamous cell carcinoma.
Ferreira do Carmo A; Dourado MR; Ervolino de Oliveira C; Bastos DC; Domingueti CB; Ribeiro Paranaíba LM; Sawazaki-Calone Í; Borges GÁ; Silva Guerra EN; Casarin RC; Graner E; Salo TA; de Almeida Freitas R; Galvão HC; Coletta RD
Exp Cell Res; 2020 Aug; 393(2):112092. PubMed ID: 32445747
[TBL] [Abstract][Full Text] [Related]
11. Identification of a stanniocalcin paralog, stanniocalcin-2, in fish and the paracrine actions of stanniocalcin-2 in the mammalian ovary.
Luo CW; Pisarska MD; Hsueh AJ
Endocrinology; 2005 Jan; 146(1):469-76. PubMed ID: 15486227
[TBL] [Abstract][Full Text] [Related]
12. Expression of Stanniocalcin 2 in Breast Cancer and Its Clinical Significance.
Jiang ST; Wang HQ; Yang TC; Wang DW; Yang LJ; Xi YQ; Kong FZ; Pan XK; Xu LH; Feng MH; Xie W; Su F
Curr Med Sci; 2019 Dec; 39(6):978-983. PubMed ID: 31845230
[TBL] [Abstract][Full Text] [Related]
13. Expression of stanniocalcin-1 and stanniocalcin-2 in laryngeal squamous cell carcinoma and correlations with clinical and pathological parameters.
Zhou H; Li YY; Zhang WQ; Lin D; Zhang WM; Dong WD
PLoS One; 2014; 9(4):e95466. PubMed ID: 24743310
[TBL] [Abstract][Full Text] [Related]
14. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
Meyer HA; Tölle A; Jung M; Fritzsche FR; Haendler B; Kristiansen I; Gaspert A; Johannsen M; Jung K; Kristiansen G
Eur Urol; 2009 Mar; 55(3):669-78. PubMed ID: 18450365
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of high expression of stanniocalcin-2 in hepatocellular carcinoma.
Wang Y; Wu J; Xu J; Lin S
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30962272
[TBL] [Abstract][Full Text] [Related]
16. Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia.
Law AY; Wong CK
Exp Cell Res; 2010 Feb; 316(3):466-76. PubMed ID: 19786016
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of clinicopathological significance, BIRC7, and STC2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.
Yuan Y; Yang ZL; Zou Q; Li JH; Li DQ; Liang LF; Zeng GX; Chen SL
Neoplasma; 2013; 60(6):698-705. PubMed ID: 23906305
[TBL] [Abstract][Full Text] [Related]
18. STC2 overexpression mediated by HMGA2 is a biomarker for aggressiveness of high-grade serous ovarian cancer.
Wu J; Lai M; Shao C; Wang J; Wei JJ
Oncol Rep; 2015 Sep; 34(3):1494-502. PubMed ID: 26165228
[TBL] [Abstract][Full Text] [Related]
19. Stanniocalcin 2 is induced by estrogen and promotes growth in endometrial cancer via AMPK pathway.
Wang Q; Wang Q; Zhao Y
Chin J Physiol; 2023; 66(2):111-117. PubMed ID: 37082998
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma.
Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X
J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]